Zentiva, a.s. (BSSE:1SKF401E)

Market Cap	48.61M -88.0%
Revenue (ttm)	36.17M -74.1%
Net Income	2.29M -94.3%
EPS	1.41 -94.3%
Shares Out	1.62M
PE Ratio	21.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	4
Open	30.00
Previous Close	n/a
Day's Range	30.00 - 30.00
52-Week Range	29.00 - 45.00
Beta	-0.37
RSI	47.43
Earnings Date	n/a

About Zentiva, a.s.

Zentiva, a.s. offers international non-proprietary names (INN) and branded generics, specialty products, and consumer healthcare solutions in Czech Republic, Romania, and Slovakia and internationally. The company provides pharmacovigilance and regulatory services for both prescription (RX), non-prescription (OTC), and non-medicinal products. It also offers bioequivalent and value-added medicines; and pharmaceuticals, including solids, injectable solutions, eye drops, sterile ointments, hormones, APIs, and intermediates. The company was formerly...

• Industry: Pharmaceutical Preparations
• Founded: 1488
• Employees: 90
• Stock Exchange: Bratislava Stock Exchange
• Ticker Symbol: 1SKF401E

Financial Performance

In 2018, Zentiva, a.s.'s revenue was 36.17 million, a decrease of -74.65% compared to the previous year's 142.68 million. Earnings were 2.29 million, a decrease of -97.06%.